Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma
Anticancer Research · 2023
DOI: 10.21873/anticanres.16731 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anticancer Research, 2023. Verfasst von Laura A Sordillo und 1 weiteren Autor:innen. Beteiligte Einrichtung: The City College of New York, New York, NY, U.S.A.; LASORDILLO@gmail.com. Hauptthemen laut MEDLINE: Kynurenine 3-Monooxygenase, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The City College of New York, New York, NY, U.S.A.; LASORDILLO@gmail.com.
- Lenox Hill Hospital, New York, NY, U.S.A.
Zitieren
APA
Sordillo, L. A., & Sordillo, P. P. (2023). Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.16731
Vancouver
Sordillo LA, Sordillo PP. Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma. Anticancer Research. 2023. doi:10.21873/anticanres.16731
BibTeX
@article{Sordillo2023,
author = {Sordillo, Laura A and Sordillo, Peter P},
title = {Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16731}
}
EUVIMED